OA
CVS icon

Operose Advisors’s CVS Health CVS Stock Holding History

Operose Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-465
Closed -$31.5K – 412
2025
Q1 		$31.5K Sell
465
-125
-21% -$7.48K 0.01% 245
2024
Q4 		$26.5K Sell
590
-1,873
-76% -$105K 0.01% 254
2024
Q3 		$155K Sell
2,463
-327
-12% -$19.1K 0.05% 163
2024
Q2 		$165K Sell
2,790
-685
-20% -$42.8K 0.06% 151
2024
Q1 		$277K Buy
3,475
+78
+2% +$5.96K 0.09% 130
2023
Q4 		$268K Sell
3,397
-1,625
-32% -$116K 0.11% 94
2023
Q3 		$351K Sell
5,022
-1,770
-26% -$125K 0.14% 71
2023
Q2 		$470K Buy
6,792
+2,800
+70% +$199K 0.21% 46
2023
Q1 		$297K Sell
3,992
-141
-3% -$11.8K 0.15% 49
2022
Q4 		$385K Buy
4,133
+1,041
+34% +$100K 0.21% 35
2022
Q3 		$295K Hold
3,092
– – 0.19% 41
2022
Q2 		$287K Hold
3,092
– – 0.2% 40
2022
Q1 		$313K Sell
3,092
-491
-14% -$51.6K 0.22% 48
2021
Q4 		$370K Buy
+3,583
New +$331K 0.3% 37

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Operose Advisors's CVS Position: Q2 2025 in Review

Operose Advisors sold out of CVS Health (CVS) in Q2 2025, closing a stake of 465 shares — an estimated $31.5K sold.

Operose Advisors first reported a position in CVS in Q4 2021 and held it in 14 quarters. The position peaked at $470K in Q2 2023. 1,757 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

  • Operose Advisors reported no remaining CVS Health position as of Q2 2025 after selling out during the quarter.
  • Operose Advisors sold 465 CVS Health shares in Q2 2025, an estimated $31.5K.
  • Operose Advisors first reported a position in CVS Health in Q4 2021 and held it in 14 quarters.
  • Operose Advisors's CVS Health position peaked at $470K in Q2 2023.
  • 1,757 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on Operose Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.